HOME HELP FEEDBACK SUBSCRIPTIONS ALL ISSUES SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a Colleague Similar articles in this journal Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Sakauye, K. M. Articles by Ford, P. A. Search for Related Content PubMed Articles by Sakauye, K. M. Articles by Ford, P. A.

Effects of Buspirone on Agitation Associated With Dementia

Department of Geriatric Psychiatry, LSU Medical Center; the Woldenberg Center for Gerontological Studies, Touro Infirmary, New Orleans; and the Department of Psychology, University of New Orleans, Louisiana.

Ten patients with probable Alzheimer's disease participated in an open-label study of buspirone for agitation. The starting dose of 15 mg/day was increased by 5 mg every week until maximal improvement or 60 mg/day was reached. A significant decrease in agitation scores occurred at an average dose of 35 mg/day.

This article has been cited by other articles:

				K. L. Lanctôt, N. Herrmann, and P. Mazzotta Role of Serotonin in the Behavioral and Psychological Symptoms of Dementia J Neuropsychiatry Clin Neurosci, February 1, 2001; 13(1): 5 - 21. [Abstract] [Full Text]

				J. W. Hawkins, J. R. Tinklenberg, J. I. Sheikh, C. E. Peyser, and J. A. Yesavage A Retrospective Chart Review of Gabapentin for the Treatment of Aggressive and Agitated Behavior in Patients With Dementias Am J Geriatr Psychiatry, August 1, 2000; 8(3): 221 - 225. [Abstract] [Full Text]

				P. N. Tariot, L. S. Schneider, and I. R. Katz Anticonvulsant and Other Non-neuroleptic Treatment of Agitation in Dementia J Geriatr Psychiatry Neurol, October 1, 1995; 8(1): S28 - S39. [Abstract] [PDF]